Nivolumab Trumps Ipilimumab as First-Line Melanoma Therapy

Nivolumab Trumps Ipilimumab as First-Line Melanoma Therapy
The anti–programmed death 1 (PD-1) antibody nivolumab alone or in combination with another immune checkpoint antibody, ipilimumab, resulted in at least a doubling of the median time to disease progression in treatment-naïve metastatic melanoma …
Read more on Cancer Network

Nedaplatin Improves on Cisplatin in Advanced Lung SCC
The second-generation platinum compound nedaplatin in combination with docetaxel improved outcomes over cisplatin and docetaxel in a phase III trial of advanced squamous cell carcinoma (SCC) of the lung (abstract 8004). Results were presented at the …
Read more on Cancer Network

WBRT Controls Brain Metastases But Does Not Impact Survival
Whole brain radiation therapy (WBRT) helps control the growth of brain metastases in patients with 1 to 3 small brain metastases, but it does not significantly extend patient survival, according to the results of a phase III trial presented at the 2015 …
Read more on Cancer Network

This entry was posted in Searchmedica and tagged , , , , , . Bookmark the permalink.